Abdominal Pain, Common Cold, Constipation, Dyspepsia, Flatulence, Human Influenza, Immunization
Conditions
Brief summary
Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on Immunity and Physical Intestinal Canal
Interventions
DIETARY_SUPPLEMENTYili Mei Yi Tian active lactobacillus drink
100ml of Yili Mei Yi Tian active lactobacillus drink to be taken once per day at 10am daily during the 84-days intervention
DIETARY_SUPPLEMENTrecombined milk drink contains no lactobacillus
100ml of recombined milk drink contains no lactobacillus to be taken once per day at 10am daily during the 84-days intervention
Sponsors
Inner Mongolia Yili Industrial Group Co., Ltd
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 25 to 45 years sub-health white-collars, catch cold for 4 to 6 times in last year, with low immunity; * Non-specific and/or moderate constipation; * Irregular or occasional gastrointestinal disorders (flatulence, gurgling, feeling heavy after eating, abdominal pain); * Slow transit or irregular bowels movements (abnormal feces solidity, bowel movements decreased, e.g. every 2-3 days or less than 3 times per week); * Able to understand the nature and purpose of the study including potential risks and side effects; * Willing to consent to study participation and to comply with study requirements
Exclusion criteria
* Diagnosed as immunity-low associated with chronic disease; * Diagnosed as chronic constipation; * Treated gastrointestinal symptoms; * Currently suffering from diarrhea; * Suffering from rhinitis chronic, laryngitis, labored breathing that similar to flu symptoms. Such as chronic allergic rhinitis, asthma, COPD; * Treatment by analgesic such as aspirin and paracetamol; * Had laxatives or other remedies to promote digestion 2 weeks prior to the study start; * Consuming dairy products or supplements containing pro/pre-biotic 10 days prior to the study start; * Long-term use of any prescription or OTC medication that inhibit or prevent flu symptoms, including but not limited to, antihistamine, pectoral, high doses of vitamin C; * Recent use (within 3 months of screening) of any prescription or OTC medication that significantly affects immune response, such as antibiotic; * Recent inoculation (within 6 months of screening) of influenza vaccine, or other vaccine in 15 days; * History of alcohol, drug, or medication abuse; * Pregnant or breastfeeding women; * Participation in another study with any investigational product within 3 months of screening * Any comorbidity that could, in the opinion of the investigator, preclude the subject's ability to successfully and safely complete the study or that may confound study outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in constipation condition | Baseline & 3 months |
| Assess severity of flu symptoms | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Change in immune markers such as antibodies and interleukins | Baseline & 3 months |
| Change in gut resident flora | Baseline & 3 months |
Countries
China
Outcome results
None listed